Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Reassures Patients Of Generic Drug Quality Amid Questions In Media Analysis

Feb 24 2019

• By Derrick Gingery

Anti-recessionary injection (vaccination) by hundred dollar denomination close up on a black background

Related Content

Culture Clash: FDA Tries to Re-Educate Indian Firms on Processes and Accurate Reporting

Oct 01 2013

The Next New Thing In FDA Inspections: Poor Root Cause Investigations

Jan 07 2019

FDA Expects Drug GMP Warning Letter Tally To Reach 90 This Year

Sep 28 2018

Gottlieb Issues Statement On Adverse Event Limitations – An Attempt To Quell Fears?

Oct 03 2017

Culture Clash: U.S. FDA Tries to Re-educate Indian Firms on Processes And Accurate Reporting

Oct 10 2013

FDA's Woodcock Expresses Concern Not All Generics Are Equivalent, But OGD May Have Solution

Nov 01 2010

Additional Topics

United States Drug Safety Generic Drugs Manufacturing Regulation FDA BioPharmaceutical

More from Drug Safety

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window